DOI QR코드

DOI QR Code

The Guidelines for the Nomenclature of Drugs

의약품명명법 가이드라인

  • Choi, Myoeng-Sin (Division of Drug Standardization, Department of Drug Evaluation, Korea Food and Drug Administration) ;
  • Choi, Bo-Kyung (Division of Drug Standardization, Department of Drug Evaluation, Korea Food and Drug Administration) ;
  • Han, Kyu-Won (Ewha Womans University) ;
  • Kim, Kil-Soo (Ewha Womans University) ;
  • Jang, Seung-Jae (Division of Drug Standardization, Department of Drug Evaluation, Korea Food and Drug Administration) ;
  • Kang, Chan-Soon (Division of Drug Standardization, Department of Drug Evaluation, Korea Food and Drug Administration)
  • 최명신 (식품의약품안전청 의약품평가부) ;
  • 최보경 (식품의약품안전청 의약품평가부) ;
  • 한규원 (이화여자대학교) ;
  • 김길수 (이화여자대학교) ;
  • 장성재 (식품의약품안전청 의약품평가부) ;
  • 강찬순 (식품의약품안전청 의약품평가부)
  • Published : 2002.12.20

Abstract

Nonproprietary name may be used without restriction by the public at large and can be called common name, generic name. Nomenclature agencies exist in US, Great Britain, Japan and so on. The agencies maintain liaison with onε another in an effort to secure the wide adoption of thε most appropriate and universally acceptable designation for each drug. To prevent the confusion which arises when several nonproprietary names are used for a single drug, either in the same country or in several different countries, the WHO has assumed the responsibility of coordination existing nomenclature at the international level. In this study, the nomenclature for new drugs and the terminology to harmonize specifications for revision of Korean Pharmacopoeia (KP) were established.

Keywords

References

  1. 보건복지부, 대한약전 제7개정 (1997)
  2. The United States Pharmacopoeia 24, United States Phar- macopoeial Convention, Inc. (1999)
  3. 일본약국방 제13개정 해설서, 광천서점 (1996)
  4. British Pharmacopoeia, Medicines Commission, London, (1998)
  5. 무기화합물명명법, 대한화학학회 (1998)
  6. 유기화합물명명법, 대한화학학회 (1999)
  7. 유기화학.생화학명명법 上,下, 남강당 (1989)
  8. 한국산업규격(KSA 0011:1987) '물체색의 색이름'